AP
ALKERMES PLC
ALKS· Health Care· PharmaceuticalsS&P 600
Close · 12/11/2026
46.98
1D
-1.90%52-week range
27 – 55.67
Volume
31,25,400.00
Price history
ALKS
14/10/2026 to 12/11/2026
O 46.00 H 48.30 L 45.27
1W+5.48%
1M+20.21%
3M-4.24%
6M+22.47%
1Y+38.95%
3Y+86.06%
5Y+54.79%
MAX+53.93%
Fundamentals
as of 12/11/2026- Market cap
- $7.89B
- Shares out
- 168.04M
- P/E (forward)
- 34.76
- EPS (trailing)
- 0.00
- Dividend yield
- 0.00%
- Beta
- 0.23
- Profit margin
- -0.02%
- P/B
- 4.23
- Return on equity
- -0.02%
SEC financial statements
50 quarterly and 17 annual periods through 30/09/2026.
Details
- Ticker
- ALKS
- Index
- SP600
- Sector
- Health Care
- Industry
- Pharmaceuticals
- HQ
- -
Last close 12/11/2026.
Tracked by Congress
1 filer · 0 on watchlist · 2 buys · 0 sells · D: 2
- 29/09/2026Gilbert CisnerosBuyAlkermes plc - Ordinary Shares$1,001–$15,000
- 30/07/2026Gilbert CisnerosBuyAlkermes plc - Ordinary Shares$15,001–$50,000